GLENMEDE TRUST CO NA - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 242 filers reported holding BEAM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$216,000
-49.2%
4,552
-38.8%
0.00%
-50.0%
Q1 2022$425,000
-27.7%
7,437
+0.7%
0.00%
-33.3%
Q4 2021$588,000
-7.1%
7,387
+1.4%
0.00%0.0%
Q3 2021$633,000
-33.0%
7,287
-0.8%
0.00%
-40.0%
Q2 2021$945,000
+166.2%
7,343
+65.4%
0.01%
+150.0%
Q1 2021$355,000
+45.5%
4,440
+48.0%
0.00%
+100.0%
Q4 2020$244,000
+234.2%
3,0000.0%0.00%
Q3 2020$73,0003,0000.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,346,934$74,937,60345.33%
HSG Holding Ltd 796,089$25,419,1222.91%
Deep Track Capital, LP 1,317,316$42,061,9001.95%
Redmile Group, LLC 1,485,199$47,422,4041.82%
ARK Investment Management 8,382,595$267,656,2461.77%
Casdin Capital, LLC 570,000$18,200,1001.59%
Yiheng Capital Management, L.P. 463,800$14,809,1340.80%
Temasek Holdings (Private) Ltd 4,317,789$137,867,0030.80%
Alphabet Inc. 321,604$10,268,8150.55%
FARALLON CAPITAL MANAGEMENT LLC 3,441,522$109,887,7970.55%
View complete list of BEAM THERAPEUTICS INC shareholders